Literature DB >> 25854391

Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.

Sahar Gohari-Lasaki1, Jalal Gharesouran, Morteza Ghojazadeh, Vahid Montazeri, Seiied Moitaba Mohaddes Ardebili.   

Abstract

TP53 is assumed to be a very important tumour suppressor gene, as illustrated by recent reports that have shown effects of its polymorphisms on breast cancer risk. Arg72Pro and PIN3(16bp duplication) polymorphisms are proposed to have an effective role in structural changes of p53 and have therefore attracted interest as a risk factor for breast cancer in different populations. The aim of this study was to examine and determine whether p53 codon 72 and PIN3 Ins16 bp may be associated with an increased risk for breast cancer in female patients from the northwest of Iran. Genotyping was performed by PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) method for a total of 100 women with breast cancer and 100 healthy women without any background of cancer, focusing on the TP53 Arg72Pro-16Del/Ins haplotypes and the combined genotypes. The results in this study established no statistical significant distinctions between the genotypes and allele frequency were found for Arg72Pro and PIN3 Ins 16 bp polymorphisms between patients and controls.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25854391     DOI: 10.7314/apjcp.2015.16.7.2971

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.

Authors:  Ankita Kumari; Charu Bahl; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Mol Biol Rep       Date:  2016-09-10       Impact factor: 2.316

2.  "p53 Polymorphism at Codon 72 and Breast Cancer" - Letter.

Authors:  Fahimeh Afzaljavan; Alireza Pasdar
Journal:  J Cancer Prev       Date:  2017-03-30

Review 3.  Association of p53 codon 72 Arg>Pro polymorphism and risk of cancer in Iranian population: A systematic review and meta-analysis.

Authors:  Daem Roshani; Alina Abdolahi; Shima Rahmati
Journal:  Med J Islam Repub Iran       Date:  2017-12-27

4.  Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.

Authors:  Brehima Diakite; Yaya Kassogue; Guimogo Dolo; Oumar Kassogue; Mamadou Lassine Keita; Brian Joyce; Erin Neuschler; Jun Wang; Jonah Musa; Cheick Bougari Traore; Bakarou Kamate; Etienne Dembele; Sellama Nadifi; Mercy Isichei; Jane L Holl; Robert Murphy; Seydou Doumbia; Lifang Hou; Mamoudou Maiga
Journal:  BMC Med Genet       Date:  2020-07-03       Impact factor: 2.103

5.  The Dilemma of TP53 Codon 72 Polymorphism (rs1042522) and Breast Cancer Risk: A Case-Control Study and Meta-Analysis in The Iranian Population.

Authors:  Fahimeh Afzaljavan; Negin Chaeichi Tehrani; Mahdi Rivandi; Saeed Zarif Ghasemian; Elham Vahednia; Reza Khayami; Mohammad Abavisani; Alireza Pasdar
Journal:  Cell J       Date:  2019-10-14       Impact factor: 2.479

6.  Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women.

Authors:  Matteo Floris; Giovanna Pira; Paolo Castiglia; Maria Laura Idda; Maristella Steri; Maria Rosaria De Miglio; Andrea Piana; Andrea Cossu; Antonio Azara; Caterina Arru; Giovanna Deiana; Carlo Putzu; Valeria Sanna; Ciriaco Carru; Antonello Serra; Marco Bisail; Maria Rosaria Muroni
Journal:  Oncol Lett       Date:  2022-08-08       Impact factor: 3.111

7.  No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.

Authors:  Weiming Hao; Xia Xu; Haifeng Shi; Chiyu Zhang; Xiaoxiang Chen
Journal:  Eur J Med Res       Date:  2018-10-11       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.